...
首页> 外文期刊>Angewandte Chemie >A Convergent Total Synthesis of the Telomerase Inhibitor (±)-γ-Rubroinycin
【24h】

A Convergent Total Synthesis of the Telomerase Inhibitor (±)-γ-Rubroinycin

机译:端粒酶抑制剂(±)-γ-红霉素的聚合全合成

获取原文
获取原文并翻译 | 示例
           

摘要

The total synthesis of the human telomerase inhibitor y-rubromycin in its racemic form was accomplished in 3.8% overall yield. The key feature of this synthesis is an efficient acid-catalyzed spiroketalization for the construction of the spiroketal core. The required electronically well-balanced spiroketal precursor was obtained by the convergent assembly of a naphthyl-substituted aldehyde, an a-melhoxy-allyl-y-silyl-substituted phosphonate as the central C., building block, and a highly functionalized aryl Grignard reagent. Another key feature is the late-stage construction of the isocoumarin moiety and a simultaneous protodesilylalion furnishing the known methyl aryl ether protected precursor of y-rubromycin.
机译:外消旋形式的人类端粒酶抑制剂γ-红霉素的总合成以3.8%的总收率完成。该合成的关键特征是有效的酸催化螺酮缩合,以构建螺缩酮核心。通过收敛组装萘基取代的醛,α-甲氧基-烯丙基-y-甲硅烷基取代的膦酸酯作为中心碳,结构单元和高度官能化的芳基格氏试剂,可得到所需的电子平衡的螺环酮前体。另一个关键特征是异香豆素部分的后期构建和同时的原甲硅烷基硅藻土提供了γ-鲁布霉素的已知甲基芳基醚保护的前体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号